Haemonetics Corp reports results for the quarter ended March 31 - Earnings Summary

Haemonetics

08/05/2025 13:26

Haemonetics Corp HAE.N reported quarterly adjusted earnings of $1.24​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of 90 cents.  The mean expectation of ten analysts for the quarter was for earnings of $1.22 per share. Wall Street expected results to range from $1.17  to $1.28 per share.

Revenue fell 3.7% to $330.60 million from a year ago; analysts expected $329.38 million.

Haemonetics Corp's reported EPS for the quarter was $1.17​.

The company reported quarterly net income of $57.98 million.

Haemonetics Corp shares had risen by 1.1% this quarter and lost 17.7% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 2.4% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 1 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Haemonetics Corp is $97.50

This summary was machine generated from LSEG data May 8 at 12:26 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
1.22
1.24
Beat
Dec. 31 2024
1.17
1.19
Beat
Sep. 30 2024
1.07
1.12
Beat
Jun. 30 2024
1.01
1.02
Beat